Particularly, hyperprolactinemia is associated with disorders of glucose and insulin metabolism (1–4, 8, 9), clinically translated in impaired glucose tolerance, insulin resistance, and postprandial hyperinsulinemia (1–4, 8, 9) together with reduced insulin sensitivity (10) either in obese or non-obese patients. This evidence concerns the gene INS and hyperprolactinemia.